UPDATE 1-EU agency backs new drugs from J&J, Lilly and Takeda

LONDON, March 21 (Reuters) - European regulators have recommended approval of new pills for hepatitis C and diabetes from Johnson & Johnson and Eli Lilly, together with Takeda's injectable drug for bowel disorders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.